This episode explores the innovative concept of adaptive trial designs in early-phase clinical trials, focusing on how these designs improve efficiency by allowing modifications based on interim data. We explain how adaptive designs differ from traditional fixed designs, offering greater flexibility and the ability to learn as the trial progresses. Several adaptive features are discussed, including dose adjustments, sample size adjustments, treatment selection, patient population enrichment, and endpoint modification. Real-world examples from various therapeutic areas, such as oncology and neurology, illustrate how these adaptations are applied in practice. The regulatory considerations surrounding adaptive designs, particularly the importance of pre-specification and adherence to FDA and ICH guidelines, are emphasized.

Beyond the technical ...